InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Bir Dawn Carter, Directeur Commercial. Director active across 2 companies, notably Reata Pharmaceuticals INC. In total, 13 filings have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €7.1m. Activity tracked since 3 January 2022. The latest transaction was filed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bir Dawn Carter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
3,991 股0Common StockSEC:0001415889-25-016355:0
13,000 股0Common StockSEC:0001415889-24-021503:0
33,805 股Class A common stockSEC:0000899243-23-019542:0
807 股@ US$169.03671.8% 占其流量Class A common stockSEC:0001209191-23-046282:0
40,000 股@ US$164.535784.1% 占其流量Class A common stockSEC:0001209191-23-043986:1
40,000 股Class A common stockSEC:0001209191-23-043986:0
4,125 股0Class A common stockSEC:0001209191-23-041927:0
894 股@ US$85.091.0% 占其流量Class A common stockSEC:0001209191-23-030167:0
9,317 股@ US$86.7710.6% 占其流量Class A common stockSEC:0001209191-23-018924:0
48,370 股Class A common stockSEC:0001209191-23-017258:0
2,166 股@ US$88.24912.5% 占其流量Class A common stockSEC:0001209191-23-016278:0
15,675 股0Class A common stockSEC:0001209191-23-000872:0
35,000 股0Class A common stockSEC:0001209191-22-001638:0
13 条申报中的 13 条
About Bir Dawn Carter
Bir Dawn Carter is Directeur Commercial and appears in 13 filings. Across the 13 sampled filings from 2022-01-05 to 2025-06-09, the activity consists only of sales totaling EUR 7126790, with transactions involving Reata Pharmaceuticals INC and Soleno Therapeutics INC, the largest being a sale of EUR 5994693.778983086 on 2023-08-01 at Reata Pharmaceuticals INC.
